3Henny CP, Ten Care JW. Van Bronswijr H, et al. Use of a new heparinoid as anticoagulant during acute hemodialysis of patient with bleeding complications. Lancet, 1983, 28 :890.
4Nurmohamed MT, Ten Care J. Steves p, et al. Long-term efficacy and safety of low molecular weight heparin in chromic hemodialysis patient: a comparison with standard heparin. ASAIO Trarns, 1991, 37 : M459.
5Schrader J, Valentin R, Tonnis HI, et al, Low molecular weight heparin in hemodialysis and hemofiltration patients. Kidney Lnt, 1985, 28 : 823.
6Ljungberg B. A low molecuhr weight heparin fraction as an anticoagulant during hemodialysis. Clin Nephrol, 1985,24:15.
7Ljungberg B, Blomback M, Johnsson H, et al. A single dose of a low molecular weight heparin fragment for anticoagulation during bemodialysis. Clin Nephrol, 1987, 27 : 31.
8Schrader J, Stibbe W, Armstrong VW, et al. Comparison of low molecular weight heparin to standard heparin in hemodialysisihemo filtration:, kidney Int, 1988, 33 : 890.
9Janssen MJFM, Deegens JK, kapinga TH, et al. Citrate compared to low molecular weight heparin anticogulation in chronic hemodialysis patients. Kidney Int, 1996, 49:806.
